{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T03:43:17Z","timestamp":1768016597056,"version":"3.49.0"},"reference-count":47,"publisher":"American Diabetes Association","issue":"7","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"vor","delay-in-days":271,"URL":"http:\/\/www.diabetesjournals.org\/site\/license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["GSD-121812"],"award-info":[{"award-number":["GSD-121812"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000064","name":"Banting and Best Diabetes Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000064","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["CREATE"],"award-info":[{"award-number":["CREATE"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["MATCH"],"award-info":[{"award-number":["MATCH"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["DHY-121263"],"award-info":[{"award-number":["DHY-121263"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["14-50-00060"],"award-info":[{"award-number":["14-50-00060"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["FRN-119345"],"award-info":[{"award-number":["FRN-119345"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000196","name":"Canada Foundation for Innovation","doi-asserted-by":"publisher","award":["RI-11810"],"award-info":[{"award-number":["RI-11810"]}],"id":[{"id":"10.13039\/501100000196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Ontario","doi-asserted-by":"publisher","award":["G13-0002813"],"award-info":[{"award-number":["G13-0002813"]}],"id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Ontario","doi-asserted-by":"publisher","award":["NIA-6581"],"award-info":[{"award-number":["NIA-6581"]}],"id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Ontario","doi-asserted-by":"publisher","award":["CIA-7432"],"award-info":[{"award-number":["CIA-7432"]}],"id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003579","name":"University of Toronto","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003579","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,7,1]]},"abstract":"<jats:p>Diabetes strongly associates with microvascular complications that ultimately promote multiorgan failure. Altered myogenic responsiveness compromises tissue perfusion, aggravates hypertension, and sets the stage for later permanent structural changes to the microcirculation. We demonstrate that skeletal muscle resistance arteries isolated from patients with diabetes have augmented myogenic tone, despite reasonable blood glucose control. To understand the mechanisms, we titrated a standard diabetes mouse model (high-fat diet plus streptozotocin [HFD\/STZ]) to induce a mild increase in blood glucose levels. HFD\/STZ treatment induced a progressive myogenic tone augmentation in mesenteric and olfactory cerebral arteries; neither HFD nor STZ alone had an effect on blood glucose or resistance artery myogenic tone. Using gene deletion models that eliminate tumor necrosis factor (TNF) or sphingosine kinase 1, we demonstrate that vascular smooth muscle cell TNF drives the elevation of myogenic tone via enhanced sphingosine-1-phosphate (S1P) signaling. Therapeutically antagonizing TNF (etanercept) or S1P (JTE013) signaling corrects this defect. Our investigation concludes that vascular smooth muscle cell TNF augments resistance artery myogenic vasoconstriction in a diabetes model that induces a small elevation of blood glucose. Our data demonstrate that microvascular reactivity is an early disease marker and advocate establishing therapies that strategically target the microcirculation.<\/jats:p>","DOI":"10.2337\/db15-1450","type":"journal-article","created":{"date-parts":[[2016,4,6]],"date-time":"2016-04-06T02:32:52Z","timestamp":1459909972000},"page":"1916-1928","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":28,"title":["Tumor Necrosis Factor\/Sphingosine-1-Phosphate Signaling Augments Resistance Artery Myogenic Tone in Diabetes"],"prefix":"10.2337","volume":"65","author":[{"given":"Meghan","family":"Sauv\u00e9","sequence":"first","affiliation":[{"name":"Department of Physiology, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonya K.","family":"Hui","sequence":"additional","affiliation":[{"name":"Department of Physiology, University of Toronto, Toronto, Ontario, Canada"},{"name":"Toronto Centre for Microvascular Medicine, University of Toronto at the Li Ka Shing Knowledge Institute, St. Michael\u2019s Hospital, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danny D.","family":"Dinh","sequence":"additional","affiliation":[{"name":"Department of Physiology, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Warren D.","family":"Foltz","sequence":"additional","affiliation":[{"name":"Spatio-Temporal Targeting and Amplification of Radiation Response Innovation Centre, Department of Radiation Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul","family":"Momen","sequence":"additional","affiliation":[{"name":"Division of Cell and Molecular Biology, Toronto General Hospital Research Institute, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergei A.","family":"Nedospasov","sequence":"additional","affiliation":[{"name":"Engelhardt Institute of Molecular Biology and Lomonosov Moscow State University, Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Offermanns","sequence":"additional","affiliation":[{"name":"Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mansoor","family":"Husain","sequence":"additional","affiliation":[{"name":"Department of Physiology, University of Toronto, Toronto, Ontario, Canada"},{"name":"Division of Cell and Molecular Biology, Toronto General Hospital Research Institute, Toronto, Ontario, Canada"},{"name":"Department of Medicine, University of Toronto, Toronto, Ontario, Canada"},{"name":"Heart and Stroke\/Richard Lewar Centre of Excellence for Cardiovascular Research, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey T.","family":"Kroetsch","sequence":"additional","affiliation":[{"name":"Department of Physiology, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darcy","family":"Lidington","sequence":"additional","affiliation":[{"name":"Department of Physiology, University of Toronto, Toronto, Ontario, Canada"},{"name":"Toronto Centre for Microvascular Medicine, University of Toronto at the Li Ka Shing Knowledge Institute, St. Michael\u2019s Hospital, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steffen-Sebastian","family":"Bolz","sequence":"additional","affiliation":[{"name":"Department of Physiology, University of Toronto, Toronto, Ontario, Canada"},{"name":"Toronto Centre for Microvascular Medicine, University of Toronto at the Li Ka Shing Knowledge Institute, St. Michael\u2019s Hospital, Toronto, Ontario, Canada"},{"name":"Heart and Stroke\/Richard Lewar Centre of Excellence for Cardiovascular Research, University of Toronto, Toronto, Ontario, Canada"},{"name":"Keenan Research Centre at the Li Ka Shing Knowledge Institute, St. Michael\u2019s Hospital, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","published-online":{"date-parts":[[2016,4,5]]},"reference":[{"key":"2022031210383776700_B1"},{"key":"2022031210383776700_B2"},{"key":"2022031210383776700_B3","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Gerstein","year":"2008","journal-title":"N Engl J Med"},{"key":"2022031210383776700_B4","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1093\/eurheartj\/eht149","article-title":"Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I","volume":"34","author":"Paneni","year":"2013","journal-title":"Eur Heart J"},{"key":"2022031210383776700_B5","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1093\/eurheartj\/eht142","article-title":"Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II","volume":"34","author":"Beckman","year":"2013","journal-title":"Eur Heart J"},{"key":"2022031210383776700_B6"},{"key":"2022031210383776700_B7","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2009.12.004","article-title":"Glycemic control and complications in type 2 diabetes mellitus","volume":"123","author":"Stolar","year":"2010","journal-title":"Am J Med"},{"key":"2022031210383776700_B8","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1161\/ATVBAHA.114.303090","article-title":"Diabetes mellitus and ischemic diseases: molecular mechanisms of vascular repair dysfunction","volume":"34","author":"Howangyin","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022031210383776700_B9","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1161\/STROKEAHA.110.593327","article-title":"Tumor necrosis factor-\u03b1 enhances microvascular tone and reduces blood flow in the cochlea via enhanced sphingosine-1-phosphate signaling","volume":"41","author":"Scherer","year":"2010","journal-title":"Stroke"},{"key":"2022031210383776700_B10","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1161\/CIRCULATIONAHA.111.047316","article-title":"Tumor necrosis factor-\u03b1-mediated downregulation of the cystic fibrosis transmembrane conductance regulator drives pathological sphingosine-1-phosphate signaling in a mouse model of heart failure","volume":"125","author":"Meissner","year":"2012","journal-title":"Circulation"},{"key":"2022031210383776700_B11","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1161\/CIRCULATIONAHA.111.039644","article-title":"Proximal cerebral arteries develop myogenic responsiveness in heart failure via tumor necrosis factor-\u03b1-dependent activation of sphingosine-1-phosphate signaling","volume":"126","author":"Yang","year":"2012","journal-title":"Circulation"},{"key":"2022031210383776700_B12","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1161\/STROKEAHA.114.006365","article-title":"Therapeutically targeting tumor necrosis factor-\u03b1\/sphingosine-1-phosphate signaling corrects myogenic reactivity in subarachnoid hemorrhage","volume":"46","author":"Yagi","year":"2015","journal-title":"Stroke"},{"key":"2022031210383776700_B13","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.2337\/diab.43.11.1271","article-title":"Tumor necrosis factor alpha: a key component of the obesity-diabetes link","volume":"43","author":"Hotamisligil","year":"1994","journal-title":"Diabetes"},{"key":"2022031210383776700_B14","doi-asserted-by":"crossref","first-page":"e0138142","DOI":"10.1371\/journal.pone.0138142","article-title":"Sphingosine-1-phosphate signaling regulates myogenic responsiveness in human resistance arteries","volume":"10","author":"Hui","year":"2015","journal-title":"PLoS One"},{"key":"2022031210383776700_B15","doi-asserted-by":"crossref","first-page":"52487","DOI":"10.1074\/jbc.M406512200","article-title":"Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720","volume":"279","author":"Allende","year":"2004","journal-title":"J Biol Chem"},{"key":"2022031210383776700_B16","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1161\/CIRCRESAHA.110.226464","article-title":"Sphingosine-1-phosphate-dependent activation of p38 MAPK maintains elevated peripheral resistance in heart failure through increased myogenic vasoconstriction","volume":"107","author":"Hoefer","year":"2010","journal-title":"Circ Res"},{"key":"2022031210383776700_B17","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1172\/JCI0213265","article-title":"Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death","volume":"109","author":"Mungrue","year":"2002","journal-title":"J Clin Invest"},{"key":"2022031210383776700_B18","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/mrm.1910340303","article-title":"Quantification of relative cerebral blood flow change by flow-sensitive alternating inversion recovery (FAIR) technique: application to functional mapping","volume":"34","author":"Kim","year":"1995","journal-title":"Magn Reson Med"},{"key":"2022031210383776700_B19","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.bbalip.2013.11.001","article-title":"Second generation S1P pathway modulators: research strategies and clinical developments","volume":"1841","author":"Bigaud","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"2022031210383776700_B20","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/cvr\/cvt125","article-title":"Defective Nrf2-dependent redox signalling contributes to microvascular dysfunction in type 2 diabetes","volume":"100","author":"Velmurugan","year":"2013","journal-title":"Cardiovasc Res"},{"key":"2022031210383776700_B21","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1161\/01.CIR.0000041432.80615.A5","article-title":"Vascular structural and functional changes in type 2 diabetes mellitus: evidence for the roles of abnormal myogenic responsiveness and dyslipidemia","volume":"106","author":"Schofield","year":"2002","journal-title":"Circulation"},{"key":"2022031210383776700_B22"},{"key":"2022031210383776700_B23","doi-asserted-by":"crossref","first-page":"H29","DOI":"10.1152\/ajpheart.00134.2011","article-title":"Differential effects of diet-induced obesity on BKCa beta1-subunit expression and function in rat skeletal muscle arterioles and small cerebral arteries","volume":"301","author":"Howitt","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2022031210383776700_B24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1124\/jpet.108.142612","article-title":"Differential effects of diet-induced dyslipidemia and hyperglycemia on mesenteric resistance artery structure and function in type 2 diabetes","volume":"328","author":"Sachidanandam","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"2022031210383776700_B25","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S0008-6363(99)00106-6","article-title":"Increased myogenic tone in skeletal muscle arterioles of diabetic rats. Possible role of increased activity of smooth muscle Ca2+ channels and protein kinase C","volume":"43","author":"Ungvari","year":"1999","journal-title":"Cardiovasc Res"},{"key":"2022031210383776700_B26","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1161\/ATVBAHA.108.167205","article-title":"Role of advanced glycation end products with oxidative stress in resistance artery dysfunction in type 2 diabetic mice","volume":"28","author":"Su","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022031210383776700_B27","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1124\/jpet.111.191296","article-title":"Cerebral myogenic reactivity and blood flow in type 2 diabetic rats: role of peroxynitrite in hypoxia-mediated loss of myogenic tone","volume":"342","author":"Kelly-Cobbs","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"2022031210383776700_B28","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1093\/eurheartj\/eht365","article-title":"Blood pressure and diabetes: a fatal attraction","volume":"34","author":"Williams","year":"2013","journal-title":"Eur Heart J"},{"key":"2022031210383776700_B29","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2147\/DMSO.S39093","article-title":"HbA1c for diagnosis of type 2 diabetes. Is there an optimal cut point to assess high risk of diabetes complications, and how well does the 6.5% cutoff perform","volume":"6","author":"Kowall","year":"2013","journal-title":"Diabetes Metab Syndr Obes"},{"key":"2022031210383776700_B30","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.diabet.2015.04.001","article-title":"Is HbA1c a valid surrogate for macrovascular and microvascular complications in type 2 diabetes","volume":"41","author":"Bejan-Angoulvant","year":"2015","journal-title":"Diabetes Metab"},{"key":"2022031210383776700_B31","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.2165\/11585220-000000000-00000","article-title":"Influence of intensive versus conventional glucose control on microvascular and macrovascular complications in type 1 and 2 diabetes mellitus","volume":"70","author":"Mattila","year":"2010","journal-title":"Drugs"},{"key":"2022031210383776700_B32","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.jcmg.2014.06.014","article-title":"Brain imaging changes associated with risk factors for cardiovascular and cerebrovascular disease in asymptomatic patients","volume":"7","author":"Friedman","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"2022031210383776700_B33","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.2337\/diacare.27.8.1954","article-title":"Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study","volume":"27","author":"Wackers","year":"2004","journal-title":"Diabetes Care"},{"key":"2022031210383776700_B34","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00467-010-1624-9","article-title":"Microvascular disease in children and adolescents with type 1 diabetes and obesity","volume":"26","author":"Marcovecchio","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"2022031210383776700_B35","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.2174\/138920111798281054","article-title":"Role of the decreased nitric oxide bioavailability in the vascular complications of diabetes mellitus","volume":"12","author":"Masha","year":"2011","journal-title":"Curr Pharm Biotechnol"},{"key":"2022031210383776700_B36","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1016\/j.bbadis.2013.08.006","article-title":"Endothelial dysfunction - a major mediator of diabetic vascular disease","volume":"1832","author":"Sena","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"2022031210383776700_B37","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1210\/edrv.22.1.0417","article-title":"Diabetes and endothelial dysfunction: a clinical perspective","volume":"22","author":"Calles-Escandon","year":"2001","journal-title":"Endocr Rev"},{"key":"2022031210383776700_B38","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/sj.bjp.0703393","article-title":"Endothelial dysfunction in diabetes","volume":"130","author":"De Vriese","year":"2000","journal-title":"Br J Pharmacol"},{"key":"2022031210383776700_B39","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1161\/01.CIR.97.17.1695","article-title":"Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo","volume":"97","author":"Williams","year":"1998","journal-title":"Circulation"},{"key":"2022031210383776700_B40","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2337\/diabetes.55.02.06.db05-1103","article-title":"Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo","volume":"55","author":"Nieuwdorp","year":"2006","journal-title":"Diabetes"},{"key":"2022031210383776700_B41","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1161\/ATVBAHA.109.194803","article-title":"The phosphorylation motif at serine 225 governs the localization and function of sphingosine kinase 1 in resistance arteries","volume":"29","author":"Lidington","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022031210383776700_B42","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1517\/13543784.2015.974804","article-title":"Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease","volume":"24","author":"Esser","year":"2015","journal-title":"Expert Opin Investig Drugs"},{"key":"2022031210383776700_B43","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1093\/ndt\/gfi155","article-title":"Role of inflammation in diabetic complications","volume":"20","author":"Navarro","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"2022031210383776700_B44","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2337\/diab.45.7.881","article-title":"Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM","volume":"45","author":"Ofei","year":"1996","journal-title":"Diabetes"},{"key":"2022031210383776700_B45","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1001\/archinte.166.8.902","article-title":"Effects of etanercept in patients with the metabolic syndrome","volume":"166","author":"Bernstein","year":"2006","journal-title":"Arch Intern Med"},{"key":"2022031210383776700_B46","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1159\/000088261","article-title":"Metabolic and vascular effects of tumor necrosis factor-alpha blockade with etanercept in obese patients with type 2 diabetes","volume":"42","author":"Dominguez","year":"2005","journal-title":"J Vasc Res"},{"key":"2022031210383776700_B47","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1042\/CS20010358","article-title":"Effect of lowering tumour necrosis factor-alpha on vascular endothelial function in Type II diabetes","volume":"103","author":"Bilsborough","year":"2002","journal-title":"Clin Sci (Lond)"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/diabetes.diabetesjournals.org\/syndication\/doi\/10.2337\/db15-1450","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/65\/7\/1916\/602221\/db151450.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/65\/7\/1916\/602221\/db151450.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:48:51Z","timestamp":1667407731000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/65\/7\/1916\/16097\/Tumor-Necrosis-Factor-Sphingosine-1-Phosphate"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,5]]},"references-count":47,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2016,4,5]]},"published-print":{"date-parts":[[2016,7,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db15-1450","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,5]]}}}